In particular, PUS7-mediated tRNA modification modulated the translation of tyrosine kinase 2 (TYK2)–signal transducer and activator of transcription 1 (STAT1), shedding light on its crucial role in GBM development. The gene discussed is PUS7; the disease is glioblastoma.